Evidence map›Paper›PMID 39622938›Full record

ArticleScientific reports2024

Magnetic and pH sensitive nanocomposite microspheres for controlled temozolomide delivery in glioblastoma cells.

Meysam Ahmadi, Muhammad Hossein Ashoub, Kamran Heydaryan, Sanaz Abolghasemi, Elmuez A Dawi, Ghazal Khajouei, Mahnaz Amiri

RetractedErratum issuedAbstract readRetracted Publication
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Meysam AhmadiNeuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Science, Kerman, Iran.
Muhammad Hossein AshoubDepartment of Hematology and Medical Laboratory Sciences, Faculty of Allied Medicine, Kerman University of Medical Sciences, Kerman, Iran.
Kamran HeydaryanDepartment of Medical Biochemical Analysis, Cihan University-Erbil, Kurdistan Region, Iraq.
Sanaz AbolghasemiDepartment of Microbiology, Faculty of Science, Islamic Azad University, Kerman Branch, Kerman, Iran.
Elmuez A DawiNonlinear Dynamic Research Center (NDRC), College of Humanities and Sciences, Ajman University, P.O. Box 346, Ajman, United Arab Emirates.
Ghazal KhajoueiNeuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Science, Kerman, Iran. ghazalkhajouei83@gmail.com.
Mahnaz AmiriNeuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Science, Kerman, Iran. mahnazamiri96@yahoo.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Controlled drug delivery systems have been intensively researched for cancer treatment to increase precision targeting and therapeutic efficacy. In this context, novel magnetic-/pH-sensitive graphene oxide/chitosan/iron oxide magnetic nanocomposite microspheres were synthesized. Fe

Indexed as

Drug Delivery SystemsGlioblastomaGraphiteMicrospheresNanocompositesTemozolomideAntineoplastic Agents, AlkylatingCell Line, TumorCell SurvivalChitosanDrug CarriersDrug LiberationHumansHydrogen-Ion ConcentrationMagnetite NanoparticlesAntineoplastic Agents, AlkylatingChitosanDrug Carriersgraphene oxideGraphiteMagnetite NanoparticlesTemozolomideControlled drug deliveryGlioblastomaMagnetic MicrospheresPH-sensitiveTemozolomide

Identifiers

PMID39622938
PMCPMC11612508

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.